Tuberculosis can be controlled by Dermcidin antibiotic

Image
Press Trust of India London
Last Updated : Feb 22 2013 | 7:40 PM IST
Dermcidin, a natural antibiotic, produced by our skin when we sweat, is highly effective in fighting tuberculosis germs and other dangerous bugs, according to a new research.
Research could contribute to the development of new antibiotics that could control multi-resistant bacteria, a release by the University of Edinburgh said today.
Scientists have uncovered the atomic structure of Dermcidin. Although about 1700 types of natural antibiotics are known to exist, it was unknown until now how they work.
Sweat spreads highly efficient antibiotics on our skin, which protect us from dangerous bugs.
If our skin get injured by a cut, scratch or the sting of a mosquito, antibiotic agents secreted in sweat glands, such as dermcidin, rapidly and efficiently kill invaders.
These natural substances, known as antimicrobial peptides (AMPs), are more effective in the long term than traditional antibiotics, because germs can't develop resistance against them.
The antimicrobials can attack the bugs� Achilles� heel � their cell wall, which cannot be modified quickly to resist attack.
Because of this, AMPs have great potential to form a new generation of antibiotics.
The molecule forms tiny channels perforating the cell membrane of bugs, which are stabilised by charged particles of zinc present in sweat.
As a consequence, water and charged particles flow uncontrollably across the membrane, eventually killing the harmful microbes.
Scientist found that dermcidin can adapt to extremely variable types of membrane enabling it to fend off bacteria and fungi at the same time.
The compound is active against many well-known pathogens such as tuberculosis, Mycobacterium tuberculosis, or Staphylococcus aureus.
Multi-resistant strains of Staphylococcus aureus, are insensitive towards conventional antibiotics and are difficult to treat.
Staphylococcus aureus infections can lead to life-threatening diseases such as sepsis and pneumonia.
"Our own bodies produce efficient substances to fend off bacteria, fungi and viruses. This research will help in developing infection-fighting drugs that are more effective than conventional antibiotics", said Dr Ulrich Zachariae of the University of Edinburgh�s School of Physics, who took part in the study.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 22 2013 | 7:40 PM IST

Next Story